Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies

NCT00356928 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: Cyclophosphamide
BIOLOGICAL: Donor T cells

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]